Carregant...
Economic consequences of idiopathic pulmonary fibrosis in Denmark
When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p
Guardat en:
| Publicat a: | ERJ Open Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
European Respiratory Society
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5968194/ https://ncbi.nlm.nih.gov/pubmed/29850467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00045-2017 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|